论文部分内容阅读
目的 :探讨尿毒症治疗应用血液透析联合血液灌注的疗效。方法 :选取106例尿毒症作为研究对象,随机进行分组;对照组采取血液透析治疗,而观察组采取血液透析联合血液灌注治疗;对比两组患者的临床疗效。结果 :治疗前,两组患者的Scr、Ccr、BUN、24小时尿蛋白定量表达水平均无显著性差异(P>0.05);治疗后,观察组患者的Scr、Ccr、BUN、24小时尿蛋白定量表达水平均显著低于对照组(P<0.05);观察组临床总有效率为94.34%,对照组临床总有效率为86.79%;两组数据具有统计学意义(P<0.05)。结论 :血液透析联合血液灌注治疗尿毒症的效果确切,协同提高尿毒症毒素的效率,改善患者的预后,具有临床可行性。
Objective: To investigate the therapeutic effect of hemodialysis combined with blood perfusion in the treatment of uremia. Methods: A total of 106 cases of uremia were selected as study subjects. Patients in control group were treated with hemodialysis while those in observation group were treated with hemodialysis combined with blood perfusion. The clinical efficacy was compared between the two groups. Results: Before treatment, the levels of Scr, Ccr, BUN and 24-hour urinary protein in both groups had no significant difference (P> 0.05). After treatment, Scr, Ccr, BUN and 24- (P <0.05). The total clinical effective rate was 94.34% in the observation group and 86.79% in the control group. The data of two groups were statistically significant (P <0.05). Conclusion: Hemodialysis combined with blood perfusion treatment of uremia exactly the effect of synergies to improve the efficiency of uremic toxins and improve the prognosis of patients with clinical feasibility.